Change from Baseline at Week 12 in Fasting Lipids (Modified Intent To Treat Analysis Set.

aDelayed Switch to EFV/FTC/TDF column includes subjects who were randomized to continue ABC/3TC+EFV at baseline and had at least 1 dose of EVF/FCT/TDF after switch at Week 12.bThe p-value for comparison between EFV/FTC/TDF and ABC/3TC +EFV at study Week 12 is from Wilcoxon rank sum test.cThe 95% confidence interval for the difference (EFV/FTC/TDF vs. ABC/3TC+EFV) is based on normal approximation.dThe p-value for within treatment group comparison is from Wilcoxon signed rank test.Change from Baseline at Week 12 in Fasting Lipids (Modified Intent To Treat Analysis Set.